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tionally, the rapid detection of agricultural pathogens is of
great importance as most emerging infectious diseases are
zoonoses.
doi:10.1016/j.ijid.2008.05.347
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Epidemiologic Evaluation of the Immunity Against Hepati-
tis B in Alexandria, Egypt
A. Reda, M. Arafa ∗
High Institute of Public Health, Alexandria, Egypt
Background: Hepatitis B (HB) vaccine represents one of
the major achievements in the 20th century. The most
important epidemiologic factor affecting the chronic car-
rier rate is age of infection. The earlier in life an infection
occurs, the higher the probability that this infection will
result in chronic carriage.
Methods: A seroepidemiologic study was conducted to
examine the impact of HB vaccination on the carrier state
among a vaccinated group of children (1000) compared to
a non-vaccinated group (500) aged 6 years in Alexandria,
Egypt.
Results: The rate of HbsAg positivity among the vacci-
nated group was found to be 0.8% compared to 2.2% among
the non-vaccinated group. The study showed that the efﬁ-
cacy of HB vaccine in preventing the carriage of HbsAg, 5
years after full course vaccination, was estimated to be
around 67%. However, long-term monitoring should continue
to conﬁrm the efﬁcacy of the vaccine in preventing chronic
carrier state. On the other hand, studying the exposure to
some risk factors associated with hepatitis B virus (HBV)
infection revealed more or less a similar pattern of exposure
among both vaccinated and unvaccinated children.
Conclusion: It can be concluded that the signiﬁcantly
lower rate of HbsAg positivity among the vaccinated com-
pared to the rate among the non-vaccinated is attributed to
the preventive effect of the vaccine.
doi:10.1016/j.ijid.2008.05.348
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Recombinant Hepatitis B Vaccination in Adolescents Aged
13—14 Years
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Huang
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Background: The plasma-derived hepatitis B virus (HBV)
vaccine has been replaced by recombinant HBV vaccine since
1992 in Taiwan. The duration of immunity conferred by the
recombinant HBV vaccine is unknown. This study aimed to
investigate the long-term protective efﬁcacy of recombinant
HBV vaccine and booster responses in adolescents who had
received recombinant HBV vaccine at their infancy 13—14
years ago.
Methods: In 2007, 835 13- to 14-year-old Taiwanese
healthy middle school students, who had been vaccinated
with recombinant HBV vaccines in infancy in 1993—1994,
were recruited for the screening of HBV seromarkers. The
immune responses to booster HBV vaccines were evaluated
in 573 subjects who were seronegative. A second or third
booster was given following a schedule of 0—1—6 months for
those who remained seronegative after one dose of booster.
Anti-HBs titers were checked 7—10 days after the boosters.
Results: While the HBV vaccine remained highly efﬁ-
cacious in reducing HBsAg positive rate, 71.9% of the
vaccinees had no detectable protective anti-HBs. Following
one booster dose, anti-HBs remained undetectable in 25.9%
(135/522) of subjects with complete 3-doses HBV vaccina-
tion in infancy. A second booster reduced the seronegative
rate to 6.1% (7/115). After the third booster only one subject
(14.3%, 1/7) remained seronegative.
Conclusions: Up to 25.9% percent of adolescents who
were fully vaccinated with recombinant HBV vaccine in their
infancy have lost their immune memory against HBV 13—14
years later. No immediate need of HBV booster was found as
most subjects were well protected at this stage. However,
the decay of immune memory may raise concerns about the
need for a booster vaccine for high risk groups in the long
run.
doi:10.1016/j.ijid.2008.05.349
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The purpose of the study was to assess the frequency
and type of adverse events after an inﬂuenza vaccination
in a population of health care workers, consisting of 897
adults in 7 medical centers in Iran, evaluated from October
2006 to February 2007. Fifty-seven percent of the subjects
(513 persons) were male. The mean age of the subjects
was 35.9± 8.1 years (range 19—58). In each medical center,
participants received one dose of the inﬂuenza virus sub-
unit vaccine inactivated with formaldehyde. Subjects were
evaluated 48 hours after their vaccination for symptoms
and signiﬁcant health events for possible adverse events.
Local and systemic reactions were reported by 192 (23.2%)
and 207 (26.1%) persons, respectively. The most common
adverse events to the inﬂuenza vaccine were skin red-
ness (39 cases), in duration (77 cases), pruritus (23 cases)
and pain (181 cases) as local reactions, while fever (84
cases), myalgia (142 cases), headache (94 cases) and weak-
ness (123 cases) were the most common systemic reactions.
Among all the participants, one case of Guillain-barre syn-
drome was reported. A fever of over 38.5 ◦C was found
in 1.4% of the study participants. The adverse reaction
remained more common in women than men after adjust-
ment for other factors (OR = 3.1). Occurrence of systemic
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reaction was inﬂuenced by previous vaccination side effects
(OR = 2.8) and smoking (OR = 3.8). We concluded that inac-
tivated inﬂuenza vaccine administered in healthy health
care workers did not result in potential adverse events in
this study population. However, it remains important to
assess the clinical efﬁcacy of inﬂuenza vaccine early in the
inﬂuenza season.
doi:10.1016/j.ijid.2008.05.350
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Background: We present a study thas has as objective to
determinate the sanitary and socioeconomic impact in vac-
cinated schoolchildren and their families with the virosomal
subunit inﬂuenza vaccine, administered to children without
risk, between 3 and 14 years old
Methods:We made a prospective cohort study during the
inﬂuenza season 2005—2006. The studied was carried out
in Bren˜a Alta, town in La Palma Island, and in Corralejo in
Fuerteventura Island. Tha vaccine was administered in some
shools with voluntary character and with parents approval.
In parallel, and also with the parents approval the were
taken another children with similar characteristics of other
schools of the same towns as control cohort. We set up in
both cases inclusion an exclusion criterions. To built on the
Database, and to make up the statistical analysis, we used
the SAS Sistem
Results: In total we recruit 329 children, 216 vaccinated
(66%, and 113 no vaccinated (34%). In both cohorts, the per-
centages male and female was very similar (55% of females
in vaccination cohort and 56% in no vaccinated). Themedium
age in the vaccinated cohort was 7,12 years more less 0,45,
and in the no vaccinated cohort 7,32 years more less 0,57.
As for the observed effectivities, we remarked signiﬁca-
tive statistical differences in the number of fever breathing
processes between vaccinated children (40%) and no vac-
cinated (73% p < 0,00001). The remarked differences come
about in the lower aged children (between 3 and 8 years
old, p < 0,001). Between 9 an 14 years old, it was not appre-
ciated. Once the fever breathing power came over the were
no difference in lasting between the two cohorts. The con-
suption of sanitary resorts was similar in both cases, but as in
vaccinated cohort there were less fever cases, overall vac-
cinated cohort had less sanitary resorts consumption. The
secondary effects in relation with the vaccine administra-
tion were scarce (27%), being the pain and discomfort the
most frecuently
Conclusion:We observed the effectivites of the vaccine,
as for a lower cases of fever process in vaccinated, as well
as a lower consumption of theese in sanitary recours
doi:10.1016/j.ijid.2008.05.351
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Inﬂuenza is a major health threat for patients and per-
sonnel in dental clinics.The objective of this study was
to evaluate the level of knowledge, attitude and vaccina-
tion against inﬂuenza among dental health care workers
(DHCW) and students. This survey was conducted in Febru-
ary and March 2005 on 348 DHCW and students from the
Faculty of Dentistry, University Kebangsaan Malaysia (UKM).
The knowledge level of inﬂuenza was low with an aver-
age score of 62.4%. The knowledge level was dependent
of the education level and occupation of the respon-
dents. Dental students had a signiﬁcantly higher knowledge
level than DHCW (p < 0.05). The average score of atti-
tude towards inﬂuenza vaccination was 88.7%. The attitude
level was dependent of the education level and occupa-
tion of the respondents. Dental students had a signiﬁcantly
higher attitude level than DHCW (p 0.05). Only 6.61% of
respondents reported being vaccinated against inﬂuenza.
Vaccination rate was higher (p < 0.05) among DHCW com-
pared to students. In conclusion, more efforts should be
made to improve the level of knowledge, attitude and
vaccination status for inﬂuenza among DHCW and stu-
dents.
doi:10.1016/j.ijid.2008.05.352
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Background: The oral poliovirus vaccine (OPV) is one of
the safest vaccines, and is usually given to an individual in
three or four subsequent doses. However, vaccine viruses
often cause rapid reversion to the neurovirulent genotype
during repeated replication in the alimentary tract. As long
as OPV is in use, the virulent vaccine-derived poliovirus
(VDPV) continues to be excreted with the feces to the envi-
ronment, and the VDPVs have caused new epidemics of
poliomyelitis in the world. We attempt to assess the efﬁ-
cacy of Japan’s vaccination policy, a 2-dose administration
of OPV, against virulent VDPVs.
Methods: VDPVs were isolated from the rivers and a
sewage disposal plant in Toyama Prefecture, Japan. The
neurovirulence of the VDPVs was analyzed by the MAPREC
(mutant analysis by PCR and restriction enzyme cleavage)
method, designed to estimate the ratio of revertants in
a virus population. The neutralizing test of 191 individual
